Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Huayi Taikang Pharmaceutical is a high-tech pharmaceutical company based in Haikou, China, specializing in the research, development, and manufacturing of high-end generic drugs with a focus on modified-release formulations. The company operates state-of-the-art facilities that have passed inspections by the US FDA, EU GMP, and China NMPA, allowing it to supply global markets. Its product portfolio includes sustained-release treatments for chronic conditions such as diabetes, hypertension, and central nervous system disorders. Huayi Taikang is recognized for being among the first Chinese firms to successfully export complex oral solids to the United States market. In addition to its internal pipeline, the company provides comprehensive CDMO services for oral solid dosage forms to global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Huayi Taikang Pharmaceutical.